Sulfogaiacol
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162652This classification denotes an antitussive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 713AJ00NPG. European Medicines Agency schedules Sulfogaiacol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10740MIG. Sulfogaiacol generally arises in the molecular formula C7H8O5S.K. The term SULFOGAIACOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, no. 3 1962, list 4.) SULFOGAIACOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule sulfogaiacol under HS 29095010 and SITC 51617. Sulfogaiacol bears US NLM identifiers UMLS ID C0061930 and NCI Concept Code C90776. SMILES: C1=CC=C(C(=C1)OCO)S(=O)(=O)[O-].[K+].
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.